EcoDrugPlus

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSECRG00000022517
Gene Symbol: IMPDH2
3 Cross references
202 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSECRG00000008279
Gene Symbol: INPP5D
3 Cross references
216 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSECRG00000022961
Gene Symbol: IGF1R
3 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSECRG00000015724
Gene Symbol: INSR
3 Cross references
290 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSECRG00000008261
Gene Symbol: ITGA4
3 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSECRG00000004591
Gene Symbol: ITGA5
3 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSECRG00000006970
Gene Symbol: ITGAV
3 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSECRG00000004926
Gene Symbol: ITGB1
3 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSECRG00000021901
Gene Symbol: ITGB3
3 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSECRG00000009021
Gene Symbol: ITGB5
3 Cross references
212 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSECRG00000006925
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSECRG00000008194
Gene Symbol: ITGB7
3 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).